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Abstract
The CRISPR/Cas9 system has been implemented in a variety of model organisms to mediate site-directed mutagenesis. A
wide range of mutation rates has been reported, but at a limited number of genomic target sites. To uncover the rules that
govern effective Cas9-mediated mutagenesis in zebrafish, we targeted over a hundred genomic loci for mutagenesis using a
streamlined and cloning-free method. We generated mutations in 85% of target genes with mutation rates varying across
several orders of magnitude, and identified sequence composition rules that influence mutagenesis. We increased rates of
mutagenesis by implementing several novel approaches. The activities of poor or unsuccessful single-guide RNAs (sgRNAs)
initiating with a 59 adenine were improved by rescuing 59 end homogeneity of the sgRNA. In some cases, direct injection of
Cas9 protein/sgRNA complex further increased mutagenic activity. We also observed that low diversity of mutant alleles led
to repeated failure to obtain frame-shift mutations. This limitation was overcome by knock-in of a stop codon cassette that
ensured coding frame truncation. Our improved methods and detailed protocols make Cas9-mediated mutagenesis an
attractive approach for labs of all sizes.
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Introduction
There is an urgent need for precise, predictable, inexpensive,
and easy-to-use genome engineering tools that are applicable to a
wide range of model organisms and cell types. Existing genome
editing tools such as zinc-finger nucleases (ZFNs) and transcription
activator-like effector nucleases (TALENs) have enabled reverse
genetics in many systems [1], but their widespread adoption has
been limited by the cost of commercially available reagents, a
requirement for substantial molecular cloning, and/or unpredict-
able activity. The CRISPR/Cas system of bacterial adaptive
immunity has been recently applied to genome editing in many
model organisms [2,3]. Briefly, the S. pyogenes Cas9 enzyme uses a
short CRISPR RNA that directs cleavage through its comple-
mentarity to 20 bases of genomic DNA sequence, and a trans-
activating RNA that induces sequence-specific double-strand
breaks in targeted DNA adjacent to an NGG trinucleotide known
as the protospacer adjacent motif (PAM). The CRISPR RNA and
the trans-activating RNA can be fused to generate a single-guide
RNA (sgRNA) sufficient for site-directed cleavage of target DNA
[4]. This simplified system has been implemented in a variety of in
vivo settings, resulting in efficient mutagenesis by NHEJ-mediated
small insertions or deletions [5–9]. A primary advantage of the
Cas9 method over existing methods is that mutagenesis can be
directed to diverse genomic locations by simply exchanging the
sgRNA, without the need to reengineer the Cas9 enzyme. This
flexibility and the published rates of mutagenesis (comparable or
superior to ZFNs and TALENs) make Cas9 an attractive system
for site-directed mutagenesis.
Despite the rapid progress in Cas9-mediated genome engineer-
ing, several questions and limitations remain. Only a small
number of loci have been targeted in model organisms. For
example, in zebrafish [9–15], only 21 genes have been targeted.
Thus, the sequence rules for sgRNA effectiveness and the
spectrum of generated alleles remain unknown. Moreover, the
optimal methods for generating and delivering sgRNAs and Cas9
enzyme are still unclear. For example, in zebrafish, the current
design of sgRNAs restricts the targeting range to a subset of the
genome and it has been claimed that Cas9 protein injection
generates only modest indel frequencies [9,11]. Here we address
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e98186these questions by targeting a large number of genomic loci in
zebrafish using an optimized Cas9 system and detecting mutations
with next-generation sequencing.
Materials and Methods
Detailed protocols for implementation are available as Supple-
mental Protocols S1.
Ethics Statement
All vertebrate animal work was performed at the facilities of
Harvard University, Faculty of Arts & Sciences (HU/FAS). The
HU/FAS animal care and use program maintains full AAALAC
accreditation, is assured with OLAW (A3593-01), and is currently
registered with the USDA. This study was approved by the
Harvard University/Faculty of Arts & Sciences Standing Com-
mittee on the Use of Animals in Research & Teaching under
Protocol No. 25–08.
Target site selection for the initial screen
Briefly, target sites were selected in exons across the genome
that matched the sequence GG-N19-GG, GA-N19-GG, or AG-
N19-GG. These sites were checked for uniqueness in RefSeq
protein coding regions using Bowtie [16] and the initially defined
specificity rules [6], which suggested an intolerance for mismatches
in the 39 twelve bases of the target site.
Cas9 cloning and protein expression
For in vivo expression of Cas9, the Cas9 open reading frame was
amplified from hCas9 [5] and cloned into the pCS2 vector to
generate pCS2-Cas9. For in vitro expression of Cas9, the hCas9
open reading frame cloned into pET-28b to generate pET-28b-
Cas9-His. Cas9 protein was expressed in E. coli Rosetta cells
(Novagen) using the auto-induction method [17], growing for
12 hours at 37uC, followed by 24 hour expression at 18uC.
Purification was performed using his-tag resin (G-Biosciences).
Buffers were 20 mM Tris pH 8, 30 mM Imidazole, 500 mM NaCl
for washes and 20 mM Tris pH 8, 500 mM Imidazole, 500 mM
NaCl for elutions. Fractions were dialyzed into 20 mM Tris,
200 mM KCl, 10 mM MgCl2 and single-use aliquots were frozen
in liquid nitrogen and stored at 280uC. Plasmids are available
from Addgene at http://www.addgene.org/Alex_Schier/.
sgRNA template generation and transcription
To generate templates for sgRNA transcription, gene-specific
oligonucleotides containing the T7 (59-TAATACGACTCAC-
TATA-39) or SP6 (59- ATTTAGGTGACACTATA-39) promoter
sequence, the 20 base target site without the PAM, and a
complementary region were annealed to a constant oligonucleo-
tide encoding the reverse-complement of the tracrRNA tail
(Supplementary Figure S1 and Table S1). The ssDNA overhangs
were filled in with T4 DNA polymerase (NEB), and the resulting
sgRNA template were purified using Qiaquick columns (Qiagen).
sgRNAs were transcribed using Megascript kits (Ambion). All
Figure 1. Cas9 directs a wide range of indel frequencies depending on sgRNA base composition. A. (left) Embryo survival at 24–30 hpf
compared to indel frequency. 59GG is black, 59GA is blue, 59AG is red. (right) Distribution of sgRNAs by indel frequency. B. G/C content of sgRNAs
compared to indel frequency. Means for each category are indicated in red and the mean across all sgRNAs is indicated in blue. C. Heatmap plot
showing position-specific effects on indel rates for nucleotide positions 3–21 (21 is the first base of the PAM). Color scale represents the increase in
indel frequency of a given sgRNA containing the indicated nucleotide at the specified position. D. sgRNA 59 dinucleotide pair compared to indel
frequency.
doi:10.1371/journal.pone.0098186.g001
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nium actetate/ethanol. Cas9 mRNA was transcribed from
linearized template DNA using mMachine SP6 kit (Ambion),
DNase treated, and precipitated with lithium chloride. RNA
concentration was quantified using Nanodrop spectrophotometer
and diluted and aliquoted as a 500 ng/ul 206stock (sgRNAs) or
600 ng/ul 26stock (Cas9 mRNA).
Fish husbandry and microinjection
For the initial screen, zebrafish TLAB strain zygotes were
collected and injected through the chorion with a mix of 25 pg
sgRNA, 300 pg Cas9 mRNA, and phenol red dye in a single mix.
Embryos were grown to 24–30hpf and genomic DNA extracted
from pools of 8–10 embryos (unless otherwise indicated) using the
HotSHOT method [18]. For comparison between Cas9 mRNA
and protein, higher levels of sgRNA were co-injected (200–300
pg). Cas9/sgRNA complex was formed by incubating protein with
sgRNA at room temperature for 5 minutes before injection.
Determination of somatic mutagenesis rates
To determine indel percentage using sequencing, a fusion PCR
method was used to attach Illumina P5 sequencing adapters and
barcodes to amplicons designed to surround the target site (Table
S1). Amplicons were quantified by visualization on agarose gel
before being pooled at roughly equal molar ratios. Pools of
amplicons were gel extracted and sequenced with MiSeq Personal
Sequencer (Illumina), 150 bp paired-end sequencing.
Each pair of reads was assigned to the correct loci based on
comparing the start of the sequenced reads (corresponding to the
amplicon primers) to the loci sequence. A match was required for
both reads for the pair to be associated with a locus. Next, both
reads were aligned to the locus using the Needleman-Wunsch
algorithm. A gap open penalty of 50 and an extend penalty of 0
Figure 2. 59GG dinucleotide pair and promoter choice influence sgRNA activity. A. Indel frequencies of 59GG sgRNAs modified with the
addition of a 59adenine. B. Indel frequencies of sgRNAs modified by substituting the 59 dinucleotide as indicated. C. Indel frequencies of sgRNAs
transcribed using either T7 (repeated data from above) or SP6 polymerase. Altered bases to the template are indicated in bold, mismatched bases to
the genome are underlined.
doi:10.1371/journal.pone.0098186.g002
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or one gap of unknown length present.
A paired end read was considered to originate from a cut site if
it differed in length (i.e. contained an indel) by more than 1 nt in
comparison to the genome reference locus sequence [19]. In the
few cases where the two reads disagreed on the length, the most
conservative estimate was considered. Even some wild-type loci
have putative indels, likely due to genomic heterogeneity, technical
artifacts or sequencing errors, and therefore overall indel
frequency was calculated as the indel frequency of the reads from
Figure 3. Cas9 generates minimal allele diversity. Target sites and alleles are shown for four genes for pools of embryos or single embryos
(n=12 per target with Cas9 mRNA, n=12 per target with Cas9 protein). For each target site, the top panel is from a pool of embryos while the
bottom panel represents alleles from single embryos. Each plot indicates the observed mutant alleles using arches that connect the bases
surrounding the deletion. In the top panel, the y-axis and color of the arch indicate allele abundance; for ease of visualization, the bottom panel
indicates allele abundance only with color. PAM is indicated on the DNA sequence in uppercase. gria3a sgRNA induces only low indel frequencies
when injected with Cas9 mRNA.
doi:10.1371/journal.pone.0098186.g003
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represented by the uninjected embryos.
Position specific biases were calculated by taking the mean cut
rate for all sgRNAs that have a given nucleotide at a given
position. The cut rate fold change was further calculated by taking
log2 of this value over the mean cut rate for all sgRNAs.
Stop codon cassette oligonucleotide design and
injection
Each oligonucleotide contained two 20 base homology arms
which flank the predicted Cas9-mediated breakpoint. These
homology arms surround the stop codon cassette, with sequence
59-GTCATGGCTAATTAATTAAGCTGTTGTAG-39. Embry-
os were injected as previously described, except with a mix of Cas9
protein/sgRNA complex and 1 mM oligonucleotide.
Verifying germline transmission of stop cassette insertion
Clutches of 20 embryos were collected from crossing adult
injected fish with uninjected wild-type fish. The isolated genomic
DNA was used for PCR amplification with a gene-specific primer
and a primer specific to the inserted sequence.
Figure 4. Overcoming allele biases by inserting stop codon oligonucleotide with injected Cas9/sgRNA complexes. A. Diagram of
Cas9/sgRNA complex injection. B. Purified His-tagged Cas9 protein complexed with sgRNA (n=12 embryos per target) or Cas9 mRNA and sgRNA
(n=12 embryos per target) were injected and indel frequency measured in single embryos at 1 dpf. C. Diagram of a stop codon oligonucleotide and
genomic target site for mezzo. D. Clutches of embryos from adult injected fish were screened by PCR for germline transmission using PCR with a
gene-specific primer and a primer specific to the inserted sequence (top panel), or two primers specific to the genome (bottom panel) as a positive
control. Specific products indicated with arrows, non-specific product indicated with an asterix. E. DNA sequence of a mezzo insertion allele
transmitted through the germline, 6/16 embryos in this clutch contained this mutation.
doi:10.1371/journal.pone.0098186.g004
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Previous studies of ,20 genes have shown that Cas9-mediated
mutagenesis is effective in zebrafish [9–15]. To understand the
rules underlying optimal sgRNAs, we extended these studies by
targeting 122 loci in the zebrafish genome and used MiSeq deep
sequencing to analyze indel frequencies and compositions. We
used the previously described 59GG-N18-NGG sgRNA architec-
ture, while also relaxing the first two bases to allow 59AG-N18-
NGG or 59GA-N18-NGG target sites for some loci, since these
were previously suggested to be acceptable as initiating bases for
T7 RNA polymerase [9]. We chose target sites most likely to
generate a null allele in the target gene via NHEJ-generated indels.
As a simple approach to reduce Cas9-mediated off-target
mutations, we predicted possible off-targets in the genome using
the previously identified in vitro and in vivo determined rules for
targeting specificity (see Materials and Methods).
We developed a simple, scalable and cloning-independent
method for generating sgRNAs that requires only a single
oligonucleotide per target sequence (Figure S1). This method
generates a template for in vitro transcription of sgRNAs containing
the constant region shown to mediate the highest rates of
mutagenesis [20]. Cas9 mRNA and sgRNA were co-injected into
zebrafish zygotes, survival was scored at 24–30 hours post-
fertilization (hpf) and genomic DNA was prepared from injected
and uninjected embryos. PCR was used to amplify ,120–300
base pairs of genomic sequence surrounding the targeted locus and
to attach barcoded sequencing adapters. These amplicons were
purified, pooled, and subjected to sequencing using MiSeq to
obtain 1–2 million 26150 base paired-end reads. We adapted a
previously implemented algorithm to determine indel frequency
[19], and improved it to account for technical artifacts and
sequencing errors (see Materials and Methods).
85% of the sgRNAs induced somatic mutations with a mean
indel frequency of 17.7%, ranging across several orders of
magnitude (Figure 1A). There was no correlation between survival
rate and mutagenic activity. Many sgRNAs induced indel
frequencies .50%, suggestive of extensive biallelic conversion
(Figure 1A). This high level of mutagenesis indicates that Cas9 is
an effective method for generating targeted mutations in zebrafish,
in agreement with previously published results [9,10,12,13,15].
We used our large dataset to investigate several aspects of sgRNA
sequence composition to determine rules which governed effec-
tiveness. We observed a positive correlation between G/C content
and indel frequency (Figure 1B). Segregating the indel frequencies
of sgRNAs by nucleotide position revealed that sgRNAs with a
guanine adjacent to the PAM motifs exhibited significantly higher
indel frequencies than other bases (Figure 1C). These biases
confirm and extend a genome-scale assessment of Cas9 affinity for
sgRNAs in tissue culture cells, which indirectly indicated similar
G/C content and purine biases associated with sgRNA activity
[21]. These results indicate that sgRNAs with over 50% G/C
content and with a G adjacent to the PAM motif are optimal for
ensuring high rates of mutagenesis.
We observed a bias for sgRNAs generated from transcription
reactions initiating with the dinucleotide 59 AG to have poor or no
activity. While embryos injected with sgRNAs templated to initiate
with a 59AG, 59GA, and 59GG had similar survival rates
(Figure 1A) and transcription reaction efficiencies, 59AG sgRNAs
exhibited poor mutagenic activity in vivo, on average 5-fold worse
than 59GG sgRNAs (Figure 1D). 59GA sgRNAs showed a less
pronounced decrease in indel frequency. To determine whether
the 59adenine directly impacts sgRNA quality, several highly
active 59GG sgRNAs were modified by adding a single adenine
base to the 59 ends, and their mutagenic capacities were assayed in
vivo. The mutagenic activity of all three sgRNAs tested was
reduced 2 to 12-fold by addition of a 59 adenine (Figure 2A),
indicating that the 59A prevented mutagenic activity independent
of genomic location. To test whether G-to-A substitutions (instead
of additions) of 59GG sgRNAs would alter activity, 59GG sgRNAs
were converted to 59GA, 59AG, and 59AA. In all cases, the
mutagenic activity of the sgRNA was reduced by these base
substitutions (Figure 2B). Based on these results, we hypothesized
that 59GG may be sufficient to improve the mutagenic activity of
poor 59AG or 59GA sgRNAs. We converted several ineffective
59AG or 59GA sgRNAs to 59GG sgRNAs and observed up to 10-
fold increases in indel frequency (Figure 2B). We conclude that (i)
Cas9 can tolerate single base mismatches between the genome and
the 59end of the sgRNA, in agreement with previous studies
[6,13], and (ii) that these changes can improve activity.
We hypothesize that the poor activity of 59AG or 59GA sgRNAs
is caused by T7-derived in vitro transcription errors or heteroge-
neity caused by attempted initiation with bases other than 59GG,
as previously described [22–24]. Alternatively, Cas9 enzyme may
bias against 59AG or 59GA sgRNAs, though this seems unlikely
given published activities of sgRNAs containing alternative 59
dinucleotides generated by in vitro transcription-independent
methods [5,6]. To distinguish between these two possibilities, we
generated several 59GG or 59 GA sgRNAs using SP6 RNA
polymerase (Figure 2C). In contrast to T7 polymerase, the SP6
polymerase consensus initiation site is 59GA [25]. These sgRNAs
should be identical in sequence to those previously generated by
T7 polymerase. When we assayed the sgRNAs for in vivo activity,
we observed that all 59GA sgRNAs that previously exhibited poor
activity when transcribed by T7, now elicited strong mutagenesis
(Figure 2C). We conclude that the previous poor activity of 59AG
or 59GA sgRNAs was at least partially due to 59 end transcript
heterogeneity from in vitro transcription using T7 polymerase.
Additionally, SP6-derived 59GG sgRNAs were equally effective as
T7-derived sgRNAs. Although these data come from a limited set
of sgRNAs, they suggest that SP6 is a more flexible and thus
superior polymerase for in vitro synthesis of sgRNAs.
In addition to determining indel frequencies for targets, we used
our deep sequencing data to investigate the diversity of mutant
alleles. We discovered that many targets had a surprisingly small
number of predominant mutant alleles, even within a pool of ten
embryos (Figure 3, top panels). To exclude the possibility that
PCR amplification reduced diversity during library preparation,
we prepared genomic DNA from individual embryos at 24–30 hpf
and profiled somatic allele diversity. For all four targets tested,
specific mutant alleles were found to predominate in nearly all
embryos (Figure 3, lower panels). Indeed, analysis of the initial
screen sequencing data revealed that fewer than five alleles
predominated for most genes, suggesting widespread allele bias
after Cas9-mediated double strand breaks. We found that the
recurrent somatic alleles remained predominant in the germline
for the five genes that were tested. For certain genes, the
predominant alleles were not generating frame-shifting mutant
alleles (for example camk2g1 in Figure 3), which makes generating
mutants for protein-coding genes less predictable. These results
suggest that the DNA repair machinery corrects breaks in a
stereotyped and genome position-specific fashion, reducing allele
diversity.
We developed two improvements to our Cas9 methodology.
First, we hypothesized that injecting Cas9 protein would be more
effective than Cas9 mRNA because it could act immediately
following injection without a translational delay. However, a
recent publication showed only weak mutagenesis (#12% indel
Mutagenesis by Cas9 Protein-Mediated Oligonucleotide Insertion
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complexes [11]. We expressed a His-tagged Cas9 protein in E. coli
and purified it using standard nickel-based affinity purification
(Figure 4A). We co-incubated Cas9 protein and sgRNA at room
temperature to form the Cas9 protein/sgRNA complex in vitro,
microinjected the complex into zygotes and assayed indel
frequency as before. Injection of Cas9 protein/sgRNA complex
was remarkably non-toxic (,90% survival) andinduced as high or
higher rates of mutagenesis in vivo when compared to Cas9 mRNA
injection for all four targeted genes (Figure 4B). For example,
gria3a sgRNA, which generates only moderate indel frequencies
when injected with Cas9 mRNA, exhibited 6-fold better muta-
genesis with complexed and injected with Cas9 protein. This
suggests that the limiting step for some poor sgRNAs may be
binding to Cas9 and/or in vivo instability. Second, we developed a
method for ensuring production of a translation-terminating
mutation regardless of target site DNA repair biases. Several
groups have reported knock-in of small sequences, such as protein
tags or loxP sites, using single-stranded DNA oligonucleotides in
zebrafish [10,13,15]. We used a similar insertional strategy with an
oligonucleotide containing stop codons in all frames and 20
nucleotide homology arms on both ends to mediate insertion
(Figure 4C). Regardless of indel, frame, or orientation, upon
insertion the cassette will generate an in-frame stop codon to
terminate translation of the coding region. We implemented this
strategy for three genes, and determined germline transmission in
adults by screening pools of embryos by PCR using a gene-specific
primer and an insert-specific primer. For all three genes, we
observed germline transmission of the inserted stop codon cassette
(Figure 4D). To confirm that the stop codon cassette generated an
in-frame stop codon, we sequenced germline transmitted mutant
alleles and verified that they contain the predicted insertion and a
premature termination codon (Figure 4E). In conclusion, use of
Cas9 protein and stop cassette oligonucleotide insertion led to
consistently high rates of putative null alleles inherited through the
germline.
Discussion
Our study provides a large-scale assessment of sgRNA activity
and allele diversity and introduces several improvements to the
zebrafish Cas9 mutagenesis strategy. The detailed protocols for
target site selection, sgRNA production, stop codon cassette
design, Cas9 protein purification, injection and downstream
analysis are provided on our website and in the supplement
(Figure S2, Supplemental Protocols S1) and have already been
successfully implemented by several other laboratories. While we
tested these methods exclusively in zebrafish, they will also be
adaptable to Cas9-mediated mutagenesis methods in other model
organisms.
Our study provides seven advances in our understanding and
implementation of Cas9-mediated mutagenesis. First, our screen
of more than 100 sgRNAs revealed that sgRNAs can differ in
activity across orders of magnitude. Second, our large dataset
identified rules for optimal target site selection: a threshold of 50%
G/C content and a guanine adjacent to the PAM. Third, we
expanded the Cas9 targeting range using base substitution,
confirming and extending findings from other reports [13].
Fourth, we uncovered issues with the use of T7 polymerase for
in vitro transcription of sgRNAs, and we suggest SP6 polymerase as
a superior alternative. Fifth, we demonstrated high mutation rates
by directly injecting Cas9 protein/sgRNA complexes. The
discrepancy between our observations and a previous report
demonstrating only modest activity by Cas9 protein in zebrafish
embryos [11] could be due to locus-specific effects, protein
concentration differences, and/or other technical issues. Sixth, our
deep sequencing data showed that certain alleles dominate after
DNA repair of Cas9-mediated double strand breaks, and these
predominant alleles are transmitted through the germline. Finally,
knock-in mutagenesis of a stop codon cassette ensures open
reading frame truncation regardless of predominant indel alleles.
Use of an insertion-based mutagenesis approach for open reading
frame truncations has an additional advantage: while small indel-
based mutations require laborious allele-specific genotyping assays,
the stop codon cassette can be used as a site for primer binding,
allowing rapid genotyping.
Supporting Information
Figure S1 Generating sgRNAs through template assem-
bly and in vitro transcription. A gene-specific oligo is
annealed to a constant oligonucleotide and filled in with DNA
polymerase. This template is purified and used in an in vitro
transcription reaction.
(TIF)
Figure S2 Pipeline for making mutants with Cas9.
Flowchart of Cas9/sgRNA-mediated mutagenesis.
(TIF)
Table S1 Screen results and primer design. Genomic
coordinates, target site, 59 dinucleotide, percent survival at 24 hpf,
indel frequency and primer design for amplicon sequencing for all
targets in the initial screen are provided.
(XLSX)
Supplemental Protocols S1 Detailed protocols are provided in
the Supplemental Protocols to guide users through each step of
Cas9/sgRNA-mediated mutagenesis.
(DOCX)
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